ORIGINAL RESEARCH article
Front. Rehabil. Sci.
Sec. Rehabilitation for Musculoskeletal Conditions
Volume 6 - 2025 | doi: 10.3389/fresc.2025.1576267
This article is part of the Research TopicInsights in Rehabilitation for Musculoskeletal Conditions 2023/2024View all 7 articles
Content Validity of Mobility Measures in Arthrogryposis Multiplex Congenita: Engaging Clinicians and People with Lived Experience
Provisionally accepted- 1Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada
- 2Shriners Hospital for Children, Montreal, Quebec, Canada
- 3Department of Physical Therapy, College of Health Sciences, University of Delaware, Newark, Delaware, United States
- 4Department of Occupational Therapy, College of Health and Rehabilitation Sciences, Sargent College, Boston University, Boston, Massachusetts, United States
- 5Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Lower-extremity impairment is prevalent in children with Arthrogryposis multiplex congenita (AMC), frequently leading to mobility limitations. Without AMC-specific assessment tools, clinicians and researchers often employ tools that have not been formally validated for the AMC population. This study aims to establish the content validity of commonly used mobility measures in children with AMC following the COnsensus-based Standards for health Measurement INstruments (COSMIN) and the International Classification of Functioning, Disability, and Health (ICF) framework. Methods: Items from the measures “Functional Mobility Scale (FMS), Gillette Functional Assessment Questionnaire (FAQ), Functional Independence Measure for Children (WeeFIM), and Patient-Reported Outcomes Measurement Information System (PROMIS)” were linked to the ICF categories using the refined linking rules of the ICF. Three raters conducted independent linking, and inter-rater reliability was calculated using the Kappa coefficient. An expert panel consisting of people with lived experience, clinicians and researchers reviewed the ICF codes identified by the raters and evaluated the comprehensibility, relevance, and comprehensiveness of the four measures using the COSMIN standards. The Content Validity Index (CVI) and modified Kappa (k*) were calculated. Results: Inter-rater agreement was substantial (κ = 0.79, [95% CI: 0.78- 0.84]). Most concepts (84.4%) were linked to the "Activities and Participation" domain, with a limited representation of "Environmental Factors" (8.9%) and "Body Functions" (6.7%). The CVI and k* values for most measures indicated excellent content validity (0.91 to 1), except for the PROMIS Mobility Young Adult (≤0.82). The expert panel found that measures exhibited high comprehensibility and relevance, but comprehensiveness was insufficient. Most studied mobility measures missed concepts such as pain, fatigue, mobility aids, and compensatory strategies. Conclusions: FMS, FAQ, WeeFIM, and PROMIS (Parent Proxy/Pediatric) demonstrated good content validity. However, none of these measures fully address the full spectrum of mobility experiences in children with AMC. Incorporating missing concepts, such as environmental challenges, compensatory strategies, and pain, into existing or newly developed assessment tools is essential for providing a more holistic evaluation of functional mobility. Doing so will support more comprehensive clinical assessment, improve outcome tracking, and enhance care for children living with AMC.
Keywords: Expert panel, Lived experience, Arthrogryposis, mobility, International Classification of Functioning, Disability and health, Content Validity, patient-reported outcomes
Received: 13 Feb 2025; Accepted: 21 Jul 2025.
Copyright: © 2025 Zidan, Snider, Sions, Donlevie, Cirillo, Pacey and Dahan-Oliel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ahlam Zidan, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada
Noémi Dahan-Oliel, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.